Articles From: Altra Industrial Motion Corp. Announces Acquisition of Guardian Industries to Amarin Provides Update on ANCHOR Trial SPA Agreement Rescission Appeal


BRAINTREE, Mass., July 1, 2014 (GLOBE NEWSWIRE) -- Altra Industrial Motion Corp.
Sign-up for Altra Industrial Motion Corp. Announces Acquisition of Guardian Industries investment picks
BRAINTREE, Mass., July 23, 2014 (GLOBE NEWSWIRE) -- Altra Industrial Motion Corp.
Sign-up for Altra Industrial Motion Corp. Announces Third Quarter 2014 Dividend investment picks
BRAINTREE, Mass., July 16, 2014 (GLOBE NEWSWIRE) -- Altra Industrial Motion Corp.
Sign-up for Altra Industrial Motion Corp. to Host Conference Call on Second Quarter 2014 Financial Results investment picks
BRAINTREE, Mass., Aug.
Sign-up for Altra Industrial Motion Corp. to Present at Jefferies 2014 Global Industrials Conference investment picks
BRAINTREE, Mass., July 24, 2014 (GLOBE NEWSWIRE) -- Altra Industrial Motion Corp.
Sign-up for Altra Reports Second-Quarter 2014 Results investment picks
2014/7/18
PRINCETON JUNCTION, N.J., July 18, 2014 (GLOBE NEWSWIRE) -- MISTRAS Group, Inc. (NYSE:MG) , is pleased to announce that it has signed a multi-year teaming agreement with Altran North America [Altran] (Euronext Paris:ALT) to collectively provide Engineering and Inspection Services and support those services with MISTRAS Products and Systems.
Sign-up for Altran North America and MISTRAS Group Enter Into Multi-Year Teaming Agreement investment picks
2014/9/3
Altria (MO) affirmed its full-year 2014 per-share profit outlook of $2.54 to $2.59. That represents growth of 7% to 9% over the tobacco company's 2013 profit of $2.38 a share.
Sign-up for Altria affirms full-year profit outlook investment picks
The Altria Companies Employee Community Fund (ACECF) awarded $3.1 million in grants to 142 non-profit organizations based in Virginia, Pennsylvania, Tennessee, Illinois and Kentucky.
Sign-up for Altria Companies’ Employee Fund Donates $3.1 Million to Nonprofits investment picks
2014/8/21
Altria Group, Inc. (Altria) (NYSE:MO) today announced that its Board of Directors voted to increase Altria’s regular quarterly dividend by 8.3% to $0.52 per common share versus the previous rate of $0.48 per common share.
Sign-up for Altria Increases Quarterly Dividend by 8.3% to $0.52 per Common Share investment picks
2014/9/3
Altria Group, Inc. (Altria) (NYSE:MO) is participating today in the Barclays Back-To-School Consumer Conference in Boston, Mass.
Sign-up for Altria Presents at the Barclays Back-To-School Consumer Conference; Reaffirms 2014 EPS Guidance investment picks
2014/7/22
NEW YORK (MarketWatch) -- Altria (MO) reported early Tuesday second-quarter profit of $1.26 billion, or 64 cents a share, compared with $1.27 billion, or 63 cents a share a year ago.
Sign-up for Altria Q2 adjusted profit falls shy of estimates, but sales beat investment picks
2014/7/22
Altria Group, Inc. (Altria) (NYSE:MO) today announced its 2014 second-quarter and first-half business results.
Sign-up for Altria Reports 2014 Second-Quarter and First-Half Results; Revises Full-Year EPS Guidance; and Announces New $1 Billion Share Repurchase Program investment picks
2014/8/20
Altria Group, Inc. (Altria) (NYSE:MO) will host a webcast of its business presentation at the Barclays Back-To-School Consumer Conference in Boston, Mass., on Wednesday, September 3, 2014, at approximately 12:45 p.m. Eastern Time.
Sign-up for Altria to Host Webcast from the Barclays Back-To-School Consumer Conference investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0959691001&sourceType=1 http://www.ccnmatthews.com/logos/20110608-altus200.jpg TORONTO, ONTARIO --
Sign-up for Altus Group Completes Early Redemption of 5.75% Convertible Debentures investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0968786001&sourceType=1 http://www.ccnmatthews.com/logos/20110608-altus200.jpg TORONTO, ONTARIO --
Sign-up for Altus Group Limited Announces Third Quarter Dividend investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961303001&sourceType=1 http://www.ccnmatthews.com/logos/20110608-altus200.jpg TORONTO, ONTARIO --
Sign-up for Altus Group Reports Second Quarter Financial Results for 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0958816001&sourceType=1 http://www.ccnmatthews.com/logos/20110608-altus200.jpg TORONTO, ONTARIO --
Sign-up for Altus Group Strengthens its Data and Market Research Offering Through Acquisition of RealNet investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0971610001&sourceType=1 http://www.ccnmatthews.com/logos/20110608-altus200.jpg TORONTO, ONTARIO --
Sign-up for Altus Group to Announce Third Quarter Financial Results on November 6, 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0961331001&sourceType=1 http://www.ccnmatthews.com/logos/20110608-altus200.jpg TORONTO, ONTARIO --
Sign-up for Altus Group Welcomes Janet Graham to Board of Directors investment picks
COLUMBUS, Ohio , July 22, 2014 /PRNewswire/ -- DSW Inc. (NYSE: DSW) , the leading branded footwear and accessories retailer, has announced its winner in its Shoe Lovers Care Leave Your Mark program: the Alzheimer's Association , based in Chicago, IL.
Sign-up for Alzheimer's Association Voted Winner of $75,000 Donation from DSW investment picks
WALTHAM, Mass., Sept.
Sign-up for AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors investment picks
Record Physician Demand Drives 27% Increase in U.S. Net Feraheme Revenues WALTHAM, Mass., July 29, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) , a specialty pharmaceutical company, today reported unaudited consolidated financial results for the quarter and six months ended June 30, 2014.
Sign-up for AMAG Pharmaceuticals Announces Second Quarter and Six Month 2014 Financial Results and Updates Financial Guidance for 2014 investment picks
Accelerates transformation of AMAG to a Profitable, Multi-Product Specialty Pharmaceutical Company Adds FDA-Approved Therapy Makena® and Complementary Commercial Platform to AMAG Portfolio Projected Pro Forma Combined 2015 Revenues of $350 million and Estimated Annual Cost Synergies of at least $20 million Transaction Expected to be Immediately Accretive to Adjusted Earnings Per Share Conference Call Today at 8am ET to Discuss Transaction WALTHAM, Mass., Sept.
Sign-up for AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business investment picks
LEXINGTON, Mass., July 25, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced it will report unaudited consolidated financial results for the quarter and six months ended June 30, 2014 before the U.S. financial markets open on Tuesday, July 29, 2014.
Sign-up for AMAG Pharmaceuticals, Inc. to Host Conference Call on July 29, 2014 at 8:00 a.m. ET to Discuss Financial Results for the Quarter and Six Months Ended June 30, 2014 investment picks
WALTHAM, Mass., Aug.
Sign-up for AMAG Pharmaceuticals, Inc. to Participate in Jefferies Boston Healthcare Summit investment picks
WALTHAM, Mass., Aug.
Sign-up for AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences investment picks
SAN FRANCISCO, July 7, 2014 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCBB:AMBS) , a biotechnology company focused on the discovery and development of novel diagnostics and therapeutics related to endoplasmic reticulum stress, cell cycle dysregulation, neurodegeneration and apoptosis, today announced that Gerald Commissiong, President and CEO will host and participate in a Twitter chat on Thursday, July 10, 2014 from 4-4:30pm EDT via his Twitter handle @G_Commish .
Sign-up for Amarantus' CEO to Host Twitter Chat on Thursday, July 10, 2014 at 4pm EDT investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G021607-001&sourceType=1 BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - September 12, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the Office of New Drugs (OND) within the U.S. Food and Drug Administration (FDA) has denied Amarin's appeal of FDA's rescission of the ANCHOR clinical trial Special Protocol Assessment (SPA) agreement.
Sign-up for Amarin Provides Update on ANCHOR Trial SPA Agreement Rescission Appeal investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Altra Industrial Motion Corp. Announces Acquisition of Guardian Industries to Amarin Provides Update on ANCHOR Trial SPA Agreement Rescission Appeal
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices